Moellmann, Julia <br/><br/>
Empagliflozin improves left ventricular diastolic function of db/db mice.  [electronic resource] 

 -  Biochimica et biophysica acta. Molecular basis of disease  08 2020 
 - 165807 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-260X 
<br/><br/><label>Standard No.: </label>10.1016/j.bbadis.2020.165807  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acids, Branched-Chain--blood<br/>Animals<br/>Benzhydryl Compounds--pharmacology<br/>Calcium-Calmodulin-Dependent Protein Kinase Type 2--antagonists & inhibitors<br/>Clinical Trials as Topic<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Diabetic Cardiomyopathies--drug therapy<br/>Diet, High-Fat--adverse effects<br/>Glucose--metabolism<br/>Glucosides--pharmacology<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Ketone Bodies--blood<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Ryanodine Receptor Calcium Release Channel--genetics<br/>Sarcoplasmic Reticulum--drug effects<br/>Sodium-Glucose Transporter 2--genetics<br/>Sodium-Glucose Transporter 2 Inhibitors--pharmacology<br/>Survival Analysis<br/>Ventricular Function, Left--drug effects